An artificial intelligence (AI) model designed to predict a person's biological age (age of body cells and tissues) based on ...

HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

Electrocardiogram tests may someday be used with an artificial intelligence (AI) model to detect premature aging and cognitive decline, according to a preliminary study presented at the American ...

One explanation for the findings is that ECG data can help to predict the risk of stroke, which can contribute to age-related ...

Electrocardiogram tests may someday be used with an artificial intelligence (AI) model to detect premature aging and cognitive decline, according to a preliminary study to be presented at the American ...

An artificial intelligence (AI) model designed to predict a person's biological age (age of body cells and tissues) based on ...

An artificial intelligence (AI) model designed to predict a person's biological age (age of body cells and tissues) based on ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...